Modernizing Medicine and Miraca Life Sciences Partner to Create Enhanced EMR and Pathology Lab Integration

Modernizing Medicine and Miraca Life Sciences Partner to Create Enhanced EMR 
and Pathology Lab Integration 
Enhanced Communication Between Dermatologists and Pathologists 
BOCA RATON, FL -- (Marketwired) -- 09/25/13 --  Modernizing
Medicine(R), the creator of the Electronic Medical Assistant(R)
(EMA(TM)), a cloud-based, specialty-specific electronic medical
record (EMR) system, and Miraca Life Sciences (MLS), a specialist in
the development and commercialization of subspecialty expert anatomic
pathology services, announced today that they are partnering to
develop an enhanced diagnostic data bridge.  
Pathologists normally analyze tissue samples with limited clinical
background on patients, which can delay accurate diagnoses. EMA
dermatologists and MLS pathologists will be able to share additional
diagnostic information, which can help the pathologist create a more
timely, informed and accurate analysis. 
"This is truly the future of healthcare technology," said Dr. Michael
Sherling, Chief Medical Officer and co-founder of Modernizing
Medicine. "Structured data stored in the cloud with Modernizing
Medicine's EMA EMR is the key to letting us share information with
MLS. Working together, we intend to build an enhanced system to
improve communications between dermatologists and pathologists which
should ultimately help patients -- improved patient care through
technology is what we're all about." 
Modernizing Medicine's user-friendly EMA adapts to each healthcare
provider's unique style of practice and integrates seamlessly into
the practice's workflow, saving physicians and their staff time and
increasing efficiencies. EMA's cloud-based approach to collecting and
storing patient information enables physicians to utilize the EMA
Network(TM) to create, visualize and consume treatment data to better
care for their patients. 
"Partnering with Modernizing Medicine is a natural fit, since we
share the same goals of using technology to accelerate positive
change in healthcare," said Richard Lash, MD, Chief Medical Officer
of Miraca Life Sciences. "Miraca's existing structured data based on
our consensus approach to diagnostic terminology and criteria will
complement the rich clinical information provided by Modernizing
Medicine, helping ensure the most definitive diagnoses for individual
patients while creating a powerful database to help clinicians and
pathologists improve patient outcomes." 
Available as a native iPad application or from any web-enabled Mac or
PC, Modernizing Medicine's EMA is developed by physicians for the
dermatology, ophthalmology, optometry, orthopedics and plastic and
cosmetic surgery markets. This year, Software Advice named EMA the #1
tablet EHR and the company was listed on Forbes' annual ranking of
America's Most Promising Companies.  
About Modernizing Medicine 
Modernizing Medicine(R) is transforming how healthcare information is
created, consumed and utilized in order to increase efficiency and
improve outcomes. Its product, Electronic Medical Assistant(R)
(EMA(TM)), is a cloud-based, specialty-specific electronic medical
record (EMR) system with a massive library of built-in medical
content, designed to save physicians time. Available as a native iPad
application or from any web-enabled Mac or PC, EMA adapts to each
provider's unique style of practice and is designed to interface with
hundreds of different practice management systems. Today, Modernizing
Medicine provides specialty-specific offerings for the dermatology,
ophthalmology, optometry, orthopedics and plastic and cosmetic
surgery markets, and to more than 1,000 physician practices across
the country. In 2013 Modernizing Medicine was listed at No. 47 on
Forbes' annual ranking of America's Most Promising Companies. 
About Miraca Life Sciences 
Serving more than 3,500 patients each day, Miraca Life Sciences is a
leader in providing an academic-caliber pathology laboratory with
diagnostic services in the fields of dermatology, gastroenterology,
hematology and urology. Building upon our experience with health IT,
we also offer accessible technology solutions to assist healthcare
professionals as they work towards accordance with Meaningful Use
initiatives. 
Miraca Life Sciences, a wholly owned subsidiary of Japan-based Miraca
Holdings Inc., employs a talented team of leading pathologists,
histologists, lab technicians, technology consultants, and other
medical professionals -- all driven to help provide the highest and
most up-to-date levels of diagnostic quality, enhanced workflow and
practice solutions possible. It's part of our commitment: not only to
scientific excellence, but to patients and practices. 
For more information, contact: 
Tara Auclair Ryan
561-880-2998 x321
tara.ryan@modmed.com  
Lauren Moreno
415-593-1400
modernizingmedicine@atomicpr.com